Additional requirements for HIV and HBV research laboratories and production facilities.
Summary
Your responsibility:
To implement and enforce these additional rules in research laboratories and production facilities engaged in the culture, production, concentration, experimentation, and manipulation of HIV and HBV.
EXEMPTION: | This section does not apply to clinical or diagnostic laboratories engaged solely in the analysis of blood, tissues, or organs. |
Note: | Production and research facilities: Hepatitis C (HCV) is the virus involved in most cases of parenterally transmitted (bloodborne) non-A, non-B hepatitis in the United States. Most individuals who contract HCV become chronically infected (85%) and develop chronic hepatitis (70%). It is recommended that you also follow these requirements for HCV production and research facilities. |
You must meet the requirements … | in this section: |
Prepare, review, and update a biosafety manual | |
Follow these special practices for the work area | |
Make sure these practices for contaminated material and waste are followed | |
Make sure these special practices for personal protective equipment (PPE) and other safeguards are followed | |
Protect vacuum lines | |
Use and handle hypodermic needles and syringes appropriately and safely | |
Handle all spills and accidents properly | |
Post signs | |
Provide additional training for facility employees | |
Furnish a sink for washing hands and a readily available eye wash facility | |
Make sure these additional criteria are followed for HIV and HBV production facilities | |
[Statutory Authority: RCW
49.17.010,
49.17.040,
49.17.050. WSR 15-23-086, § 296-823-180, filed 11/17/15, effective 12/18/15. Statutory Authority: RCW
49.17.010,
49.17.040,
49.17.050, and
49.17.060. WSR 04-12-070, § 296-823-180, filed 6/1/04, effective 9/1/04; WSR 03-09-110, § 296-823-180, filed 4/22/03, effective 8/1/03.]